Drug Utilization Study In Primary Glaucoma Patients Attending the Ophthalmology Outpatient Department of a Tertiary Care Hospital in Western Uttar Pradesh
Nazia Parween, Surabhi Gupta, Surinder Kumar, K. Jain, P. Khosla, S. Kansal, W. Khan
{"title":"Drug Utilization Study In Primary Glaucoma Patients Attending the Ophthalmology Outpatient Department of a Tertiary Care Hospital in Western Uttar Pradesh","authors":"Nazia Parween, Surabhi Gupta, Surinder Kumar, K. Jain, P. Khosla, S. Kansal, W. Khan","doi":"10.7869/DJO.286","DOIUrl":null,"url":null,"abstract":"Results:Out of 116 patients, 66 (56.90%) were males and 50 (43.10%) females. The mean age at presentation was 52.88±15.19 years. Primary open angle glaucoma was found to be the most common (54.0%) type, followed by primary angle closure glaucoma (41.0 %). The common group of drugs prescribed included beta blockers (38.12%), followed by carbonic anhydrase inhibitors, prostaglandin F2α analogues, α2 agonist and cholinergic agonist (14.36% each)","PeriodicalId":23047,"journal":{"name":"The Official Scientific Journal of Delhi Ophthalmological Society","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Official Scientific Journal of Delhi Ophthalmological Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7869/DJO.286","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Results:Out of 116 patients, 66 (56.90%) were males and 50 (43.10%) females. The mean age at presentation was 52.88±15.19 years. Primary open angle glaucoma was found to be the most common (54.0%) type, followed by primary angle closure glaucoma (41.0 %). The common group of drugs prescribed included beta blockers (38.12%), followed by carbonic anhydrase inhibitors, prostaglandin F2α analogues, α2 agonist and cholinergic agonist (14.36% each)
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
